Correspondence 0001104659-23-081298 from TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences, Inc.
Date: July 14, 2023 · CIK: 0001826667 · Accession: 0001104659-23-081298

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-269138

Date

July 14, 2023

Author

MedTech Acquisition Corporation

Form

CORRESP

Company

TriSalus Life Sciences, Inc.

Letter

MEDTECH ACQUISITION CORPORATION

48 Maple Avenue

Greenwich, Connecticut 06830

July 14, 2023

VIA EDGAR Correspondence

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F. Street, N.E.

Washington, D.C. 20549

Attn: Ms. Jessica Ansart

Re: Acceleration of Effective Date

MedTech Acquisition Corp

Registration Statement on Form S-4 (File No. 333-269138)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), MedTech Acquisition Corporation (the “Registrant”) hereby requests that the effective date of the above-referenced Registration Statement (the “Registration Statement”) be accelerated so that the Registration Statement becomes effective under the Securities Act at 4:00 p.m., Eastern Time, on Monday, July 17, 2023, or as soon thereafter as practicable.

The Registrant respectfully requests that you notify Mr. Kevin Schuler of Foley & Lardner LLP of such effectiveness by a telephone call to (813) 225-5441 or via email at kshuler@foley.com.

Very truly yours,
MedTech Acquisition Corporation

Show Raw Text

CORRESP
1
filename1.htm

MEDTECH
ACQUISITION CORPORATION

48 Maple Avenue

Greenwich, Connecticut 06830

July 14, 2023

VIA EDGAR Correspondence

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F. Street, N.E.

Washington, D.C. 20549

Attn: Ms. Jessica Ansart

 Re: Acceleration of Effective Date

    MedTech Acquisition Corp

    Registration Statement on Form S-4 (File
No. 333-269138)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act
of 1933, as amended (the “Securities Act”), MedTech Acquisition Corporation (the “Registrant”) hereby requests
that the effective date of the above-referenced Registration Statement (the “Registration Statement”) be accelerated so that
the Registration Statement becomes effective under the Securities Act at 4:00 p.m., Eastern Time, on Monday, July 17, 2023, or as
soon thereafter as practicable.

The Registrant respectfully requests that you notify
Mr. Kevin Schuler of Foley & Lardner LLP of such effectiveness by a telephone call to (813) 225-5441 or via email at kshuler@foley.com.

    Very truly yours,

    MedTech Acquisition Corporation

    By:
    /s/ Christopher C. Dewey

    Christopher C. Dewey

    Chief Executive Officer

SecProbe.io